TwinTela Tablet 80/5 mg

Adult dose

The recommended dose is 1 tablet once daily, taken with water independently of meals. It is recommended to take it at the same time every day (e.g., in the morning). For patients with renal impairment: Mild and moderate renal impairment do not require dose adjustment, but severe renal impairment should start at a lower dose and be gradually increased. For patients with hepatic impairment: The daily dose of Telmisartan for patients with mild or moderate hepatic impairment should not exceed 40 mg.

Child dose

The safety and efficacy of this medication in pediatric patients under 18 years of age have not been established, and its administration is not recommended.

This medication should not be used during pregnancy, particularly in the second and third trimesters, as it can pose serious risks to the fetus. Patients with hypersensitivity to the components of this medication, pregnant or breastfeeding women, those with severe liver impairment, and patients with severe hypotension should not be administered this drug. Patients with liver function impairment, valvular heart disease, or reduced kidney function should be particularly cautious when using this medication. Common side effects include dizziness and peripheral edema, but serious side effects may occur infrequently. This medication should not be used during pregnancy, and if pregnancy is confirmed, it should be discontinued immediately and an alternative treatment should be considered. Due to the risk of hypotension, patients with insufficient fluid or salt should correct their condition before taking this medication, and if symptoms of hypotension occur, appropriate measures should be taken immediately. Caution should be exercised when taking potassium supplements or medications containing potassium, as serum potassium levels may rise. Patients with impaired kidney function should take this medication while periodically checking their kidney status through blood tests. This medication may interact with other drugs, so it's essential to inform a doctor or pharmacist if taking other medications. Dizziness or drowsiness may occur, necessitating caution when driving or operating dangerous machinery. In case of overdose, symptoms such as hypotension, heart rhythm abnormalities, and dizziness may appear, requiring immediate medical attention. This medication is not recommended for children as its safety and efficacy have not been adequately established. Elderly patients may have heightened sensitivity to this medication, necessitating careful administration and possible dose adjustments. Store this medication out of reach of children, do not transfer it to another container, and open the packaging just before taking it.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headache, lightning-like headache, seizures, confusion, vision abnormalities, paralysis, urination issues

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory infection
• urinary tract infection
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia
• depression

This medication is sensitive to light and should be stored in an opaque container. It is appropriate to store it at room temperature, between 1 to 30 degrees Celsius. This helps maintain the medication's effectiveness over a longer period.

Appearance

Biconvex oval dual tablet in white and light blue colors

Package unit

30 tablets (10 tablets/PTP x 3)